Novel tool predicts patient's risk of developing psoriatic arthritis Isra Zaman14 Aug 2023 9:00 AM ISTIn research published in Arthritis & Rheumatology, investigators developed and validated a tool called PRESTO that identifies patients with...
Brepocitinib Shows Promise for Treatment of Psoriatic Arthritis Dr. Kamal Kant Kohli1 Aug 2023 9:45 AM ISTBrepocitinib, a Janus kinase inhibitor (JAKi), has demonstrated efficacy in reducing signs and symptoms of psoriatic arthritis (PsA) and is...
DNA Methylation Markers may predict Psoriatic Arthritis Jacinthlyn Sylvia23 July 2023 8:00 PM ISTIn a recent study published in the Arthritis and Rheumatology, Omar Cruz-Correa and team have made a significant stride towards predicting the...
Aurobindo Pharma arm CuraTeQ Biologics to commercialize proposed biosimilar to Stelara Ruchika Sharma8 July 2023 12:00 PM ISTCuraTeQ intends to file this product in India and Emerging Markets as early as in 2024 and the regulated markets filing is expected to begin in 2026.
Higher Levels Of Beta-Defensin 2 may Improve Clinical Response In Psoriatic Arthritis Patients Treated With Secukinumab Dr. Kamal Kant Kohli1 July 2023 8:00 PM ISTA recent study published in Rheumatic and Musculoskeletal Diseases has identified a potential biomarker that could help predict the response to...
Brepocitinib shows promising results in patients with psoriatic arthritis Dr. Kamal Kant Kohli23 May 2023 9:15 AM ISTUSA: A phase IIb randomized clinical trial published in Arthritis & Rheumatology recently generated promising efficacy and safety data for...
Secukinumab improves outcomes in active psoriatic arthritis patients: BMJ Jacinthlyn Sylvia17 May 2023 8:00 PM ISTImprovements in physical performance, health-related quality of life, and suppression of the development of structural damage were observed in...
Apremilast lowers weight and improves obese patients with psoriasis and psoriatic arthritis Dr. Mahalakshmi Sivashankaran14 May 2023 8:00 PM ISTUSA: A recent study conducted by OM1 Real-World Data Cloud has found that apremilast, a medication used to treat psoriasis and psoriatic arthritis...
Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay Ruchika Sharma11 April 2023 1:00 PM ISTKarnataka: Shilpa Medicare has recently announced that the Company has received final approval from the U.S Food and Drug...
USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz Ruchika Sharma22 March 2023 1:45 PM ISTSandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.
Zydus Lifesciences arm bags USFDA nod for ulcerative colitis drug Tofacitinib Ruchika Sharma22 March 2023 10:00 AM ISTTofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis and for the treatment of adult...
Emergency CS closely associated with women having psoriatic arthritis: BMJ Jacinthlyn Sylvia18 March 2023 9:30 AM ISTA new study published in BMJ Rheumatic & Musculoskeletal Diseases suggests that women with psoriatic arthritis (PsA) were more at risk for...
